What Is the Optimal Surrogate Indicator for a Miss Rate of Adenoma in Colonoscopy?

Affiliations

Editorial

Seung Wook Hong et al. Gut Liver. 2022.

. 2022 Sep 15;16(5):661-662.

doi: 10.5009/gnl220365.

¹ Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

No abstract available

Conflict of interest statement

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

Correlation between Surrogate Quality Indicators for Adenoma Detection Rate and Adenoma Miss Rate in Qualified Colonoscopy, CORE Study: KASID Multicenter Study.
Han JH, Kim HG, Ahn EM, Park S, Jeon SR, Cha JM, Kwak MS, Jung Y, Shin JE, Shin HD, Cho YS. Han JH, et al. Gut Liver. 2022 Sep 15;16(5):716-725. doi: 10.5009/gnl210287. Epub 2021 Dec 21. Gut Liver. 2022. PMID: 34933279 Free PMC article.

1. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977–1981. doi: 10.1056/NEJM199312303292701. - DOI - PubMed
1. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696. doi: 10.1056/NEJMoa1100370. - DOI - PMC - PubMed
1. Cha JM, Kwak MS, Kim HS, et al. Real-world national colonoscopy volume in korea: a nationwide population-based study over 12 years. Gut Liver. 2020;14:338–346. doi: 10.5009/gnl19108. - DOI - PMC - PubMed
1. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306. doi: 10.1056/NEJMoa1309086. - DOI - PMC - PubMed
1. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112:1016–1030. doi: 10.1038/ajg.2017.174. - DOI - PubMed